Paper

Antibodies against HLA-E-VL9 enhance NK cell and CD8+ T cell cytotoxicity against tumor cells and HIV-infected CD4+ T cells.

PubMed · 2026 · Joyce K Hwang, Marina Tuyishime, Daniel J Marston et al.